2024-10-19 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a leading pharmacy health care company offering prescription drugs, health and wellness products, and other services. 

**1. Performance & Valuation:**

* **Cumulative Return:** -34.25% 
* **S&P 500 (VOO) Cumulative Return:** 137.88%
* **Return Difference:** -172.13% (This means CVS has underperformed the S&P 500 by a significant margin.)
* **Relative Divergence:** 0.0 (This indicates CVS is at the lowest point of its historical performance compared to the S&P 500.)

**2. Recent Price Action:**

* **Closing Price:** $60.34
* **5-Day Moving Average:** $64.3
* **20-Day Moving Average:** $63.07
* **60-Day Moving Average:** $59.76
* **Analysis:** The stock is currently trading below all three moving averages, suggesting a potential downtrend.

**3. Technical Indicators:**

* **RSI:** 41.68 (Neutral)
* **PPO:** -0.68 (Indicates potential bearish momentum)
* **Delta_Previous_Relative_Divergence:** -0.11 (Short-term bearish)
* **Expected Return:** 0.0% (This means that in the long term, CVS is not expected to outperform the S&P 500.)

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

**Analysis:** CVS exceeded earnings expectations in the most recent quarter (2024-08-07), reporting an EPS of 1.83 compared to the expected 1.73. This positive result suggests the company may be navigating the challenging economic environment better than anticipated.

**5. News and Recent Issues:**

* CVS has been under pressure from rising inflation and labor costs, impacting its margins.
* The company is investing heavily in digitalization and expanding its healthcare services portfolio, focusing on value-based care. 
* **Analyst Opinions:** While some analysts remain optimistic about CVS's long-term prospects, others express concerns regarding its competition and pricing pressure.
* **Performance Highlights:** Despite recent underperformance, CVS continues to benefit from its strong brand recognition and wide market reach.

**6. Overall Analysis:**

CVS has been struggling in the market, underperforming the S&P 500 significantly. The stock is currently in a downtrend, with technical indicators suggesting potential bearish momentum. While the recent earnings results were positive, the company faces challenges in navigating the difficult economic environment. Despite the challenges, CVS remains a dominant player in the healthcare sector, with potential for growth in the future. 

**7. Recommendation:**

Investors should proceed with caution when considering CVS. The stock's underperformance and current downtrend suggest it may be wise to wait for further signs of improvement before investing.  Long-term investors may consider a staggered approach to invest gradually in CVS, taking advantage of potential price dips, but should closely monitor the company's performance and the broader market trends.

**Disclaimer:** This report is for informational purposes only and should not be considered investment advice. It is crucial to conduct your own research and consult with a qualified financial professional before making any investment decisions. 
